If your monthly bill climbs every time your clinician steps up your dose, here's what's happening — and how flat-rate plans avoid it.
Compounded tirzepatide is titrated: most patients start at 2.5 mg weekly and step up gradually over weeks to months toward a maintenance dose, often 10–15 mg. How a provider prices that journey falls into one of two models.
Dose-tiered pricing charges more as the dose increases. A program may advertise an attractive starter price and then raise the monthly cost at each step up. By maintenance, the price can be substantially higher than where you began.
Flat-rate (dose-independent) pricing holds one monthly price regardless of dose. The figure at 2.5 mg is the same figure at 15 mg.
There are two reasons. The first is real: a higher dose contains more active pharmaceutical ingredient, and ingredient cost is part of what a compounding pharmacy charges. The second is commercial: a low introductory price attracts sign-ups, and the increases arrive later, after a patient has already started and is less likely to switch. Neither reason is hidden or improper on its own — but it means the price you see at sign-up may not be the price you pay in month six.
Because nearly everyone titrates upward, the maintenance-dose price matters more than the starter price for total cost. As of July 2026, a dose-tiered program such as MEDVi can start near $279 and rise to roughly $399–$499 at higher doses. A flat-rate program such as NexLife ($186–$215/month) or Trimi (~$125/month on an annual plan) charges the same amount whether you are at a low or high dose. Over a year of treatment that difference can be significant. See starter price vs maintenance price for a worked comparison.
Provider pricing pages do not always state the model plainly. The reliable way to find out is to ask directly: "Does my monthly price change as my dose increases?" and "What will I pay at 10 mg and at 15 mg?" A flat-rate provider will give you one number; a dose-tiered provider will give you a schedule. See what flat-rate pricing means.
With dose-tiered providers, higher doses use more active ingredient and are often priced higher as a strategy. Flat-rate providers charge the same price across all eligible doses.
No. Some use flat, dose-independent pricing (one price for every dose) and others use dose-tiered pricing that rises as you titrate up. Confirm the model before enrolling.
It depends on your maintenance dose. Flat-rate tends to cost less over a full year and at higher doses; a dose-tiered intro can be cheaper only in the first month or two.